Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Columbus McKinnon
CMCO
$553M
| $12.2M | ﹤0.01% |
252,018
+33,414
| +15% | +$1.71M |
|
|
HAPN
1902
Happen Inc
HAPN
$2.21B
| $12.2M | ﹤0.01% |
670,279
+139,098
| +26% | +$2.16M |
|
|
HA
1903
DELISTED
Hawaiian Holdings, Inc.
HA
| $12.1M | ﹤0.01% |
496,767
+22,716
| +5% | +$586K |
|
1904
MacroGenics
MGNX
$235M
| $12.1M | ﹤0.01% |
450,484
+44,546
| +11% | +$1.3M |
|
1905
Zumiez
ZUMZ
$332M
| $12.1M | ﹤0.01% |
246,848
+417
| +0.2% | +$18.7K |
|
1906
NETGEAR
NTGR
$648M
| $12.1M | ﹤0.01% |
314,823
+9,170
| +3% | +$356K |
|
1907
PJT Partners
PJT
$4.3B
| $12M | ﹤0.01% |
168,445
+7,376
| +5% | +$527K |
|
1908
Ubiquiti
UI
$33.7B
| $12M | ﹤0.01% |
38,377
+731
| +2% | +$214K |
|
|
VBTX
1909
DELISTED
Veritex Holdings
VBTX
| $12M | ﹤0.01% |
337,532
+4,129
| +1% | +$144K |
|
1910
Vanda Pharmaceuticals
VNDA
$307M
| $11.9M | ﹤0.01% |
554,907
+144,050
| +35% | +$2.58M |
|
1911
Standex International
SXI
$3.59B
| $11.9M | ﹤0.01% |
125,050
+472
| +0.4% | +$45.7K |
|
|
CSII
1912
DELISTED
Cardiovascular Systems, Inc.
CSII
| $11.8M | ﹤0.01% |
276,858
+4,683
| +2% | +$183K |
|
1913
Palomar
PLMR
$3.55B
| $11.8M | ﹤0.01% |
156,427
+11,659
| +8% | +$841K |
|
1914
Fulgent Genetics
FLGT
$470M
| $11.8M | ﹤0.01% |
127,427
+16,044
| +14% | +$1.28M |
|
1915
Triumph Financial Inc
TFIN
$1.81B
| $11.8M | ﹤0.01% |
158,278
+4,072
| +3% | +$347K |
|
1916
Liberty Energy
LBRT
$3.05B
| $11.6M | ﹤0.01% |
821,799
+16,259
| +2% | +$219K |
|
1917
Tencent Music
TME
$15.5B
| $11.6M | ﹤0.01% |
750,145
+168,342
| +29% | +$2.79M |
|
1918
Virtu Financial
VIRT
$5.11B
| $11.6M | ﹤0.01% |
419,632
+19,832
| +5% | +$590K |
|
1919
GDS Holdings
GDS
$6.56B
| $11.6M | ﹤0.01% |
147,685
+9,384
| +7% | +$728K |
|
1920
OFG Bancorp
OFG
$2.23B
| $11.5M | ﹤0.01% |
521,842
-656
| -0.1% | -$15.6K |
|
1921
PAR Technology
PAR
$699M
| $11.5M | ﹤0.01% |
164,827
+31,181
| +23% | +$2.21M |
|
|
ECHO
1922
DELISTED
Echo Global Logistics, Inc.
ECHO
| $11.5M | ﹤0.01% |
374,673
+10,102
| +3% | +$333K |
|
1923
Varex Imaging
VREX
$472M
| $11.5M | ﹤0.01% |
428,608
+16,403
| +4% | +$402K |
|
1924
Acco Brands
ACCO
$389M
| $11.5M | ﹤0.01% |
1,326,987
+52,417
| +4% | +$466K |
|
1925
Evolent Health
EVH
$348M
| $11.4M | ﹤0.01% |
541,611
+13,225
| +3% | +$265K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.